Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

NCT00335686 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lopinavir-rtv (Kaletra): 3 capsules (600 mg)/12 h
DRUG: Nevirapine (Viramune): 1 comp (200mg)/12h

Sponsor

Germans Trias i Pujol Hospital

Collaborators

[object Object]